AUTHOR=Kang Yi , Jin Qian , Zhou Mengqi , Li Zirong , Zheng Huijuan , Li Danwen , Liu Weijing , Wang Yaoxian , Lv Jie 

TITLE=Predictive value of bone metabolism markers in the progression of diabetic kidney disease: a cross-sectional study

JOURNAL=Frontiers in Endocrinology

VOLUME=15

YEAR=2024

URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1489676

DOI=10.3389/fendo.2024.1489676

ISSN=1664-2392

ABSTRACT=<sec><title>Objective</title><p>This study aimed to investigate the relationship between bone metabolism markers, including serum klotho, fibroblast growth factor 23 (FGF23), 25(OH)D3, iPTH, calcium (Ca), and PHOS and the progression of diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM). Additionally, the predictive value of these markers for DKD progression was evaluated.</p></sec><sec><title>Methods</title><p>This study involved 126 patients with T2DM between May 2021 and March 2023. DKD staging was assessed based on urinary protein excretion rates and estimated glomerular filtration rate (eGFR). The study evaluated serum concentrations of klotho, FGF23, 25(OH)D3, iPTH, Ca and PHOS across various stages and examined their relationships with clinical parameters. Receiver operating characteristic (ROC) curve analysis was utilized to determine the predictive accuracy of these bone metabolism markers for DKD. Multivariate linear and logistic regression analyses identified risk factors linked to DKD severity.</p></sec><sec><title>Results</title><p>Among the 126 participants, 30 had non-DKD with normal proteinuria, while 96 had DKD, categorized as 31 with stage III DKD (microproteinuria), 34 with stage IV DKD, and 31 with stage V DKD (massive proteinuria). With advancing DKD from stage III to V, levels of klotho, 25(OH)D3, and Ca decreased significantly, whereas FGF23, iPTH and PHOS levels increased markedly. Klotho is significantly positively correlated with eGFR (<italic>r</italic> = 0.285, <italic>P</italic> = 0.001.) and negative correlations with serum creatinine (Scr) and UACR (<italic>r</italic> = -0.255, <italic>P</italic> = 0.004; <italic>r</italic> = -0.260, <italic>P</italic> = 0.011). FGF23 was positively related to systolic blood pressure (SBP) (<italic>r</italic> = 0.224, <italic>P</italic> = 0.012), but negatively with eGFR (<italic>r</italic> = -0.294, <italic>P</italic> = 0.001). Additionally, 25(OH)D3 exhibited significant negative correlations with several adverse clinical biomarkers, and both iPTH, Ca and PHOS were strongly associated with DKD progression (<italic>P</italic>&lt;0.05). ROC analysis showed high predictive accuracy for DKD using these bone metabolism markers, with a combined area under the curve (AUC) of 0.846. Multivariate logistic regression analysis reinforced the significance of these markers in DKD progression.</p></sec><sec><title>Conclusion</title><p>Bone metabolism markers, such as klotho, FGF23, 25(OH)D3, iPTH, Ca and PHOS are intricately linked to DKD progression and may function as valuable predictive biomarkers.</p></sec>